Product Information
TAYTULLA 1 MG-20 MCG CAPSULE is a brand product labeled by Allergan, Inc., priced at $8.9747 per EA under NDC 00023586230. Its NADAC has been published 498 times since Mar 22, 2017.
FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
TAYTULLA 1 MG-20 MCG CAPSULE
norethindrone acetate and ethinyl estradiol, and ferrous fumarateManufacturer
Allergan, Inc.NDC
00023586230
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA204426FDA Approved
4/19/2013
TE Code
AB
On Market Since
5/1/2016
Price Statistics
The NADAC for TAYTULLA 1 MG-20 MCG CAPSULE has been published 498 times since Mar 22, 2017, and over the history we have for it it has risen 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9747 per EA |
|---|---|
| All-time high | $9.0000 (May 13, 2026) |
| All-time low | $5.3666 (Mar 22, 2017) |
| 52-week high | $9.0000 |
| 52-week low | $8.5715 |
| Median price | $7.0918 |
| Average price | $7.2319 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 498 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol, and ferrous fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAYTULLA 1 MG-20 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAYTULLA 1 MG-20 MCG CAPSULE, manufactured by Allergan, Inc., is $8.9747 per EA (NDC 00023586230), effective Sep 30, 2026.
How has the price of TAYTULLA 1 MG-20 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAYTULLA 1 MG-20 MCG CAPSULE has risen 67.2%. It has been tracked across 498 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for TAYTULLA 1 MG-20 MCG CAPSULE?
Since Mar 22, 2017, the NADAC for TAYTULLA 1 MG-20 MCG CAPSULE has ranged from a low of $5.3666 (Mar 22, 2017) to a high of $9.0000 (May 13, 2026), with a median of $7.0918 per EA.
Are there cheaper alternatives to TAYTULLA 1 MG-20 MCG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HAILEY 24 FE 1 MG-20 MCG TAB, is $0.1748 per EA — about 98% below TAYTULLA 1 MG-20 MCG CAPSULE.
Who manufactures TAYTULLA 1 MG-20 MCG CAPSULE?
TAYTULLA 1 MG-20 MCG CAPSULE (NDC 00023586230) is labeled by Allergan, Inc., and CMS classifies it as a brand product.